Knoxville, TN, United States of America

Michael B Zemel

This inventor holds 32 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Nusirt Sciences, Inc., The University of Tennessee Research Foundation, Artecel Science, Inc.. Active years: 1990-2020.

USPTO Granted Patents = 32 

% Patents Active = 87.5

 


Average Co-Inventor Count = 2.5

ph-index = 14

Forward Citations = 425(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1990)
  • Heiskell, TN (US) (2013 - 2017)
  • Knoxville, TN (US) (2000 - 2020)

Company Filing History:


Years Active: 1990-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Energy Metabolism
Metabolic Pathways
Metabolic Disorders
Pulmonary Conditions
Lipid Levels
Hepatic Steatosis
Obesity Treatment
Adipocyte Modulation
Calcium Fortification
SUR1 Antagonists
Nicotinic Acid
Leucine
32 patents (USPTO):Explore Patents

Title: Michael B. Zemel: Innovator in Metabolic Research

Introduction: Michael B. Zemel is a prominent inventor based in Knoxville, TN, known for his significant contributions to the field of metabolic research. With a total of 32 patents to his name, Zemel has focused his work on compositions and methods that enhance energy metabolism and modulate metabolic pathways. His innovative research has a profound impact on weight management and metabolic health.

Latest Patents: Zemel’s latest patents include "Compositions and Methods for Increasing Energy Metabolism" and "Compositions and Methods for Modulating Metabolic Pathways." The first patent presents compositions that combine a PDE5 inhibitor, such as sildenafil or icariin, with resveratrol and branched amino acids like leucine. These compositions aim to induce weight loss, reduce weight gain, and elevate the activity of key metabolic regulators including Sirt1, Sirt3, and AMPK. The second patent explores synergistic combinations of sirtuin-pathway activators, including resveratrol, along with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), and leucine, targeting increased fatty acid oxidation and mitochondrial biogenesis.

Career Highlights: Michael B. Zemel has worked with leading organizations, including Nusirt Sciences, Inc. and the University of Tennessee Research Corporation. His career is marked by a commitment to advancing scientific understanding of metabolism and developing practical applications of his research findings.

Collaborations: Throughout his career, Zemel has collaborated with esteemed researchers such as Antje Bruckbauer and E. Douglas Grindstaff II. These collaborations have enriched his research and contributed to innovative solutions in metabolic science.

Conclusion: Michael B. Zemel's extensive patent portfolio and collaborative efforts underscore his role as a pioneer in metabolic research. His inventions promise to provide new methods for enhancing metabolic health and managing weight, reflecting his dedication to scientific innovation and practical health applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…